Omega-3 fatty acids, inflammatory status and biochemical markers of patients with systemic lupus erythematosus: a pilot study.

BACKGROUND Studies have shown that omega-3 fatty acids reduce the concentrations of eicosanoids, cytokines, chemokines, C-reactive protein (CRP) and other inflammatory mediators. OBJECTIVE To investigate the effects of omega-3 fatty acids on circulating levels of inflammatory mediators and biochemical markers in women with systemic lupus erythematosus (SLE). METHODS Experimental clinical study (clinical trial: NCT02524795); 49 women with SLE (ACR1982/1997) were randomized: 22 to the omega-3 group (daily intake of 1080mg EPA+200mg DHA, for 12 weeks) and 27 to the control group. The inflammatory mediators and biochemical markers at T0 and T1 in omega-3 group were compared using Wilcoxon test. U-Mann-Whitney test was used to compare variations of measured variables [ΔV=pre-treatment (T0)-post-treatment (T1) concentrations] between groups. p<0.05 was considered significant. RESULTS The median (interquartile range - IQR) of age was 37 (29-48) years old, of disease duration was 7 (4-13) years, and of SLEDAI-2K was 1 (0-2). The median (IQR) of variation in CRP levels between the two groups showed a decrease in omega-3 group while there was an increase in control group (p=0.008). The serum concentrations of IL-6 and IL-10, leptin and adiponectin did not change after a 12 week treatment. CONCLUSIONS Supplementation with omega-3 had no impact on serum concentrations of IL-6, IL-10, leptin and adiponectin in women with SLE and low disease activity. There was a significant decrease of CRP levels as well as evidence that omega-3 may impact total and LDL-cholesterol.

• Publication year

  2017

• Venue

  Revista Brasileira de Reumatologia

• Publication date

  2017-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.rbre.2016.09.014PMID 29173690
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ácidos graxos poli-insaturados ômega-3 e lúpus eritematoso sistêmico: o que sabemos?

  2014cited by this paper
• Effect of Marine-Derived n-3 Polyunsaturated Fatty Acids on C-Reactive Protein, Interleukin 6 and Tumor Necrosis Factor α: A Meta-Analysis

  2014cited by this paper
• [Polyunsaturated omega-3 fatty acids and systemic lupus erythematosus: what do we know?].

  2014cited by this paper
• Progression of carotid atherosclerosis in patients with systemic lupus erythematosus

  2013cited by this paper
• Intakes of PUFAs were inversely associated with plasma C-reactive protein 12 years later in a middle-aged population with vitamin E intake as an effect modifier.

  2013cited by this paper
• Omega-3 in SLE: a double-blind, placebo-controlled randomized clinical trial of endothelial dysfunction and disease activity in systemic lupus erythematosus

  2013cited by this paper
• Leptin, resistin and visfatin: the missing link between endocrine metabolic disorders and immunity

  2013cited by this paper
• Causes and predictors of death in Brazilian lupus patients

  2013cited by this paper
• Association between fish consumption, long chain omega 3 fatty acids, and risk of cerebrovascular disease: systematic review and meta-analysis

  2012cited by this paper
• Study of comparative effects of antioxidants on insulin sensitivity in type 2 diabetes mellitus.

  2012cited by this paper
• Omega 3 Fatty Acids and Cardiovascular Outcomes: Systematic Review and Meta-Analysis

  2012cited by this paper
• Dose-response effects of omega-3 fatty acids on triglycerides, inflammation, and endothelial function in healthy persons with moderate hypertriglyceridemia.

  2011cited by this paper
• Relationship between red cell membrane fatty acids and adipokines in individuals with varying insulin sensitivity

  2011cited by this paper
• Fish oil in rheumatic diseases.

  2011cited by this paper
• Association of adiponectin and leptin with serum lipids and erythrocyte omega-3 and omega-6 fatty acids in dialysis patients.

  2011cited by this paper
• Leptin and ghrelin in Korean systemic lupus erythematosus

  2010cited by this paper
• Influence of an eicosapentaenoic and docosahexaenoic acid-enriched enteral nutrition formula on plasma fatty acid composition and biomarkers of insulin resistance in the elderly.

  2010cited by this paper
• Eicosapentaenoic acid (EPA) from highly concentrated n-3 fatty acid ethyl esters is incorporated into advanced atherosclerotic plaques and higher plaque EPA is associated with decreased plaque inflammation and increased stability.

  2010cited by this paper
• Associations of dietary long-chain n-3 polyunsaturated fatty acids and fish with biomarkers of inflammation and endothelial activation (from the Multi-Ethnic Study of Atherosclerosis [MESA]).

  2009cited by this paper
• Adipocytokines in systemic lupus erythematosus: relationship to inflammation, insulin resistance and coronary atherosclerosis

  2009cited by this paper
• Effects of seafood consumption and weight loss on fasting leptin and ghrelin concentrations in overweight and obese European young adults

  2009cited by this paper
• SHORT COMMUNICATION An inverse relationship between plasma n-3 fatty acids and C-reactive protein in healthy individuals

  2009cited by this paper
• Epidemiological studies in the Upernavik district, Greenland. Incidence of some chronic diseases 1950-1974.

  2009cited by this paper
• DHA supplementation decreases serum C-reactive protein and other markers of inflammation in hypertriglyceridemic men.

  2009cited by this paper
• Inverse association of erythrocyte n-3 fatty acid levels with inflammatory biomarkers in patients with stable coronary artery disease: The Heart and Soul Study.

  2009cited by this paper
• Adipokines and Systemic Lupus Erythematosus: Relationship with Metabolic Syndrome and Cardiovascular Disease Risk Factors

  2009cited by this paper
• Potential impact of omega-3 treatment on cardiovascular disease in type 2 diabetes

  2009cited by this paper
• High Omega-3 Fat Intake Improves Insulin Sensitivity and Reduces CRP and IL6, but does not Affect Other Endocrine Axes in Healthy Older Adults

  2008cited by this paper
• Increased Adiponectin Secretion by Highly Purified Eicosapentaenoic Acid in Rodent Models of Obesity and Human Obese Subjects

  2007cited by this paper
• A randomised interventional trial of ω-3-polyunsaturated fatty acids on endothelial function and disease activity in systemic lupus erythematosus

  2007cited by this paper
• Influence of low-dose polyunsaturated fatty acids supplementation on the inflammatory response of healthy adults.

  2007cited by this paper
• The impact of long chain n‐3 polyunsaturated fatty acid supplementation on inflammation, insulin sensitivity and CVD risk in a group of overweight women with an inflammatory phenotype

  2007cited by this paper
• The effects of eicosapentaenoic acid-fortified food on inflammatory markers in healthy subjects--A randomized, placebo-controlled, double-blind study.

  2006cited by this paper
• Relationship of plasma polyunsaturated fatty acids to circulating inflammatory markers.

  2006cited by this paper
• Lipoxins and new lipid mediators in the resolution of inflammation.

  2006cited by this paper
• Adipocytokines: mediators linking adipose tissue, inflammation and immunity

  2006cited by this paper
• Cellular and Molecular Mechanisms of Regulation of Autoantibody Production in Lupus

  2005cited by this paper
• Adipose tissue as an endocrine organ.

  2004cited by this paper
• Inhibition of tumour necrosis factor-alpha and interleukin 6 production by mononuclear cells following dietary fish-oil supplementation in healthy men and response to antioxidant co-supplementation.

  2003influential reference
• Comparison of the effects of linseed oil and different doses of fish oil on mononuclear cell function in healthy human subjects.

  2003cited by this paper
• Serum leptin levels in women with systemic lupus erythematosus

  2002cited by this paper
• Systemic lupus erythematosus disease activity index 2000.

  2002cited by this paper
• Influence of dietary supplementation with long-chain n−3 or n−6 polyunsaturated fatty acids on blood inflammatory cell populations and functions and on plasma soluble adhesion molecules in healthy adults

  2001cited by this paper
• Healthy percentage body fat ranges: an approach for developing guidelines based on body mass index.

  2000cited by this paper
• Correlation of serum triglyceride and its reduction by omega-3 fatty acids with lipid transfer activity and the neutral lipid compositions of high-density and low-density lipoproteins.

  1999cited by this paper
• Leptin secretion from subcutaneous and visceral adipose tissue in women.

  1998cited by this paper
• The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus.

  1997cited by this paper
• Safety and Efficacy of Omacor in Severe Hypertriglyceridemia

  1997cited by this paper
• Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

  1997cited by this paper
• Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study.

  1997cited by this paper
• The 1982 revised criteria for the classification of systemic lupus erythematosus.

  1982cited by this paper
• The bimodal mortality pattern of systemic lupus erythematosus.

  1976cited by this paper
• [Erythematosus].

  1971cited by this paper

• Unraveling the Molecular Mechanisms of cSLE Through Integrated Serum Metabolomics, Network Pharmacology, and Molecular Docking Approaches

  2025cites this paper
• A Comprehensive Systematic Review of Natural Biomedicines for Immune-Mediated and Inflammatory Dermatologic Diseases

  2025cites this paper
• The Anti‐Lupus Plate: Mapping Nutritional Interventions to Inflammatory Pathways in Systemic Lupus Erythematosus

  2025cites this paper
• Association between Unsaturated Fatty Acid-Type Diet and Systemic Lupus Erythematosus: A Systematic Review with Meta-Analyses

  2024cites this paper
• Correction of omega-3 fatty acid deficiency and improvement in disease activity in patients with systemic lupus erythematosus treated with krill oil concentrate: a multicentre, randomised, double-blind, placebo-controlled trial

  2024cites this paper
• Association between Omega-3 fatty acids and autoimmune disease: Evidence from the umbrella review and Mendelian randomization analysis.

  2024cites this paper
• The effects of lifestyle interventions on disease activity and quality of life in patients with systemic lupus erythematosus: A systematic review.

  2024cites this paper
• The effect of Omega-3 fatty acid supplementation in systemic lupus erythematosus patients: A systematic review

  2022cites this paper
• Effects of diet on the outcomes of rheumatic and musculoskeletal diseases (RMDs): systematic review and meta-analyses informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs

  2022cites this paper
• Diet and Systemic Lupus Erythematosus (SLE): From Supplementation to Intervention

  2022influential citation
• The Influence of Dietary Intervention in Connective Tissue Diseases: Evidence from Randomized Clinical Trials

  2021cites this paper
• Diet in Rheumatoid Arthritis versus Systemic Lupus Erythematosus: Any Differences?

  2021cites this paper
• Adiponectin Deregulation in Systemic Autoimmune Rheumatic Diseases

  2021cites this paper
• Effect of omega-3 fatty acids supplementation on adipokines: a systematic review and meta-analysis of randomized controlled trials

  2021cites this paper
• Serum levels of n-3 and n-6 polyunsaturated fatty acids in patients with systemic lupus erythematosus and their association with disease activity: a pilot study

  2021cites this paper
• Regular consumption of cod liver oil is associated with reduced basal and exercise-induced C-reactive protein levels; a prospective observational trial

  2021cites this paper
• Fatty Acid Composition of Proximal Femur Bone Marrow Adipose Tissue in Subjects With Systemic Lupus Erythematous Using 3 T Magnetic Resonance Spectroscopy

  2021cites this paper
• Efficacy of flaxseed oil compared with fish oil supplementation in the treatment of coronary heart disease: a retrospective study

  2021cites this paper
• The Influence of Dietary Intervention in Connective Tissue Diseases: Evidence from Randomized Clinical Trials

  2021cites this paper
• Recent Advances in Marine-Based Nutraceuticals and Their Health Benefits

  2020cites this paper
• Effect of omega-3 fatty acids on systemic lupus erythematosus disease activity: A systematic review and meta-analysis.

  2020cites this paper
• Requisite Omega-3 HUFA Biomarker Thresholds for Preventing Murine Lupus Flaring

  2020cites this paper
• Functional Lipids in Autoimmune Inflammatory Diseases

  2020cites this paper
• Erythrocyte membrane polyunsaturated fatty acid profiles are associated with systemic inflammation and fish consumption in systemic lupus erythematosus: a cross-sectional study

  2020cites this paper
• Dietary intervention and health in patients with systemic lupus erythematosus: A systematic review of the evidence

  2019cites this paper
• A comparison between the effects of flaxseed oil and fish oil supplementation on cardiovascular health in type 2 diabetic patients with coronary heart disease: A randomized, double‐blinded, placebo‐controlled trial

  2019cites this paper
• The effects of omega‐3 fatty acids and vitamin E co‐supplementation on clinical and metabolic status in patients with Parkinson's disease: A randomized, double‐blind, placebo‐controlled trial

  2017cites this paper
• Clinical and metabolic response to flaxseed oil omega-3 fatty acids supplementation in patients with diabetic foot ulcer: A randomized, double-blind, placebo-controlled trial.

  2017cites this paper